Perioperative Management of Type-3c Gaucher's Disease for Kyphoscoliosis Correction and Spinal Cord Detethering

Abstract

Gaucher's disease (GD) is an inherited lysosomal storage disorder caused by mutations in the acid β-glucosidase (GBA) gene, leading to abnormal function of the enzyme glucocerebrosidase, which results in the accumulation of glucocerebrosides in various organs, causing multiorgan dysfunction. GD has three phenotypes, of which type-3 is the cardiovascular type with many anesthetic implications. A 20-year-old woman, genetically proven type-3 GD, was diagnosed with thoracolumbar kyphoscoliosis with fatty filum and planned for deformity correction and fatty filum excision. She had mitral and aortic stenoses, hydrocephalus, corneal opacity, a difficult airway, and chronic pain. Management of a difficult airway, hemodynamic management in double stenotic lesions, and perioperative pain management were considered as some of the challenges. The intraoperative course was complicated by massive blood loss and pneumothorax, which were managed appropriately. Perioperative pain was managed using a multimodal analgesic technique. Thorough preoperative evaluation, meticulous planning, and execution with adequate backup plans and appropriate pain management helped with faster recovery.

Keywords

aortic stenosis - type-3c Gaucher's disease - kyphoscoliosis correction - mitral stenosis - massive blood loss and transfusion

Publikationsverlauf

Artikel online veröffentlicht:
22. August 2025

• References

• 1 Kaplan P, Andersson HC, Kacena KA, Yee JD. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med 2006; 160 (06) 603-608
• 2 Grabowski GA. Recent clinical progress in Gaucher disease. Curr Opin Pediatr 2005; 17 (04) 519-524
• 3 Rosenbloom BE, Weinreb NJ. Gaucher disease: a comprehensive review. Crit Rev Oncog 2013; 18 (03) 163-175
• 4 Grass A, Riemer E, Zimran A. et al. Anesthetic approaches and perioperative complications of total hip arthroplasty in Gaucher disease: a control-matched retrospective-cohort study. Life (Basel) 2023; 13 (08) 1716
• 5 Tobias JD, Atwood R, Lowe S, Holcomb III GW. Anesthetic considerations in the child with Gaucher disease. J Clin Anesth 1993; 5 (02) 150-153
• 6 Abrahamov A, Elstein D, Gross-Tsur V. et al. Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet 1995; 346 (8981) 1000-1003
• 7 Wang YZ, Li TT, Cao HL, Yang WC. Recent advances in the neuroprotective effects of medical gases. Med Gas Res 2019; 9 (02) 80-87
• 8 Sun A, Chang IJ, Lam C, Berry GT. Lysosomal Storage Disorders. In Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics, 7th edition.. Academic Press; 2021: 563-682
• 9 Kurolap A, Del Toro M, Spiegel R. et al. Gaucher disease type 3c: new patients with unique presentations and review of the literature. Mol Genet Metab 2019; 127 (02) 138-146
• 10 Bulut FD, Kor D, Kılavuz S. et al. Expanding the phenotypic landscape of Gaucher disease type 3c with a novel entity - transient neonatal cholestasis. Eur J Med Genet 2023; 66 (06) 104764
• 11 Unger P, Pibarot P, Tribouilloy C. et al; European Society of Cardiology Council on Valvular Heart Disease. Multiple and mixed valvular heart diseases. Circ Cardiovasc Imaging 2018; 11 (08) e007862
• 12 Ng JH, Leonard I. Managing multiple valvular disease in spine surgery: A case report. JCA Advances 2025 2. 02
• 13 Rosenbaum H. Hemorrhagic aspects of Gaucher disease. Rambam Maimonides Med J 2014; 5 (04) e0039
• 14 Seki H, Ideno S, Ishihara T, Watanabe K, Matsumoto M, Morisaki H. Postoperative pain management in patients undergoing posterior spinal fusion for adolescent idiopathic scoliosis: a narrative review. Scoliosis Spinal Disord 2018; 13: 17